It went into shortage in the FDAs database in March 2022, which opened the door for certain qualified pharmacies to make compounded versions
This is because animal studies showed that the drugs can cause a specific kind of thyroid tumor, though that link hasnt been found in any studies on humans
The FDA has approved it under three brand names, each for a different purpose: Ozempic : for type 2 diabetes (approved 2017) Wegovy : for weight loss in adults and teens 12+ (approved 2021) Rybelsus : an oral tablet option for type 2 diabetes Rybelsus is currently the only oral GLP-1 option available
If you run into any issues, please reach out to our Patient Support team through the chat bubble in the bottom right corner of your account
Each semaglutide brand has different formulations, dosages, and approved uses despite containing the same active ingredient
Non-alcohol related steatohepatitis (NASH) Semaglutide has been granted Breakthrough Therapy Designation by the FDA in the NASH indication and is currently in clinical Phase III